Literature DB >> 2346731

Prevalence of haemochromatosis amongst asymptomatic Australians.

B A Leggett1, J W Halliday, N N Brown, S Bryant, L W Powell.   

Abstract

We determined the prevalence of iron overload due to homozygous haemochromatosis in an asymptomatic Australian (predominantly Caucasian) population by surveying 1968 employees of two large corporations. Subjects were screened by measurement of transferrin saturation and serum ferritin concentration and, in all subjects with elevation of both indices, percutaneous liver biopsy was performed to establish whether significant iron overload was present. The prevalence of iron overload due to haemochromatosis in this population was 0.36%. The prevalence rate was not significantly different between males and females, suggesting that this autosomal recessive disease is expressed equally in females given an adequate dietary iron supply. The positive predictive value of a transferrin saturation consistently greater than 45% together with an elevated serum ferritin concentration was 64%. It is concluded that the prevalence of significant iron overload due to homozygous haemochromatosis warranting treatment is approximately 1:300 and that transferrin saturation should be included in existing adult health screening programmes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2346731     DOI: 10.1111/j.1365-2141.1990.tb06345.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  24 in total

1.  Screening for hereditary haemochromatosis should be implemented now.

Authors:  K Allen; R Williamson
Journal:  BMJ       Date:  2000-01-15

2.  Should we genetically test everyone for haemochromatosis?

Authors:  K Allen; R Williamson
Journal:  J Med Ethics       Date:  1999-04       Impact factor: 2.903

3.  Global prevalence of putative haemochromatosis mutations.

Authors:  A T Merryweather-Clarke; J J Pointon; J D Shearman; K J Robson
Journal:  J Med Genet       Date:  1997-04       Impact factor: 6.318

4.  Elevated serum transferrin saturation and mortality.

Authors:  Arch G Mainous; James M Gill; Peter J Carek
Journal:  Ann Fam Med       Date:  2004 Mar-Apr       Impact factor: 5.166

Review 5.  Phenotypic expression of hereditary hemochromatosis: what have we learned from the population studies?

Authors:  Eng K Gan; Oyekoya T Ayonrinde; Debbie Trinder; John K Olynyk
Journal:  Curr Gastroenterol Rep       Date:  2010-02

6.  Hereditary haemochromatosis and blood donation.

Authors:  M Worwood; C Darke; P Trenchard
Journal:  BMJ       Date:  1991-03-09

7.  Homozygosity for the predominant Cys282Tyr mutation and absence of disease expression in hereditary haemochromatosis.

Authors:  D A Rhodes; R Raha-Chowdhury; T M Cox; J Trowsdale
Journal:  J Med Genet       Date:  1997-09       Impact factor: 6.318

8.  The hemochromatosis 845 G-->A and 187 C-->G mutations: prevalence in non-Caucasian populations.

Authors:  L M Cullen; X Gao; S Easteal; E C Jazwinska
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

9.  The significance of haemochromatosis gene mutations in the general population: implications for screening.

Authors:  M J Burt; P M George; J D Upton; J A Collett; C M Frampton; T M Chapman; T A Walmsley; B A Chapman
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

Review 10.  Is genetic screening for hemochromatosis worthwhile?

Authors:  Omer T Njajou; Behrooz Z Alizadeh; Cornelia M van Duijn
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.